Daphna trained as an immunologist at HUJI, and completed her postdoctoral work at Harvard Medical School, specializing in Hematology and Genetics. 

Maram completed her PhD at Ben Gurion university, and a postdoctoral fellowship at HUJI. With a passion for advancing the field of RNA biology, she is developing innovative single-cell techniques to uncover new dimensions of RNA biology. 

Ofri  studies dynamics of rRNA modifications in the hematopoietic hierarchy. She aims to uncover the molecular mechanisms that underpin stem cell function, contributing to a deeper understanding of cellular processes. 

Using whole-genome CRISPRi screens Neta studies synthetic lethal interactions in acute myeloid leukemia, with cliniclly used therapeutics. Neta's goal is to  uncover novel therapeutic targets. 

Sivan focuses on the lymphoid lineage, investigating essential rRNA modifications as potential therapeutic targets in B-cell and T-cell lymphoblastic leukemia.

Using CRISPRi-target libraries Sophie studies the role of translational machinery and translated-related factor to leukemogenesis